Atrial Fibrillation

Publication Date: 2016

Chairperson: Paulus Kirchhof & Stefano Benussi

Atrial fibrillation, Anticoagulation, Vitamin K antagonists, Non-vitamin K antagonist oral anticoagulants, Left atrial appendage occlusion, Rate control, Cardioversion, Rhythm control, Antiarrhythmic drugs, Upstream therapy, Catheter ablation, AF surgery, Valve repair, Pulmonary vein isolation, Left atrial ablation

Pocket Guidelines on Atrial Fibrillation


2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS


„Ištraukos iš 2020 m. Europos kardiologų draugijos prieširdžių virpėjimo diagnostikos ir gydymo gairių”.


„Despite good progress in the management of patients with atrial fibrillation (AF), this arrhythmia remains one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity in the world. Furthermore, the number of patients with AF is predicted to rise steeply in the coming years. To meet the growing demand for effective care of patients with AF, new information is continually generated and published, and the last few years have seen substantial progress. Therefore, it seems timely to publish this 2nd edition of the ESC guidelines on AF.”

Skaityti daugiau